Tetrahydrozoline Ophthalmic
Tetrahydrozoline ophthalmic is an eye drop used to relieve redness caused by minor eye irritation.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 31 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Tetrahydrozoline Ophthalmic: Patient Information Guide
A plain-language walkthrough of Tetrahydrozoline Ophthalmic — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Tetrahydrozoline ophthalmic eye drops are used for one purpose: relieving eye redness from minor irritation.
- Relief of redness of the eye due to minor eye irritations — available across brands including CAREALL Eyedrops Original, DG Original Eye Drops, Good Neighbor Pharmacy Eye Drops Original Formula, GoodSense Eye Drops Original Formula, Preferred Plus Pharmacy Redness Relief Eye Drops, and Redness reliever
💊How it's taken▾
Adults and children 6 years and older may place 1 or 2 drops into the affected eye(s) up to 4 times a day. Children under 6 should not use this product without first consulting a doctor, and children under 2 should not use it at all.
- Always remove contact lenses before applying the drops
- Do not touch the dropper tip to any surface to keep the solution sterile
- Replace the cap after every use
- Do not use a solution that has changed color or turned cloudy
🤒Side effects — in detail▾
Most people tolerate these drops well, but a few effects are worth knowing about:
- Temporary enlargement of the pupils
- Increased eye redness with overuse
- Eye irritation
If you experience eye pain, vision changes, or redness that persists or worsens beyond 72 hours, stop using the drops and contact your doctor right away.
⚠️Warnings & precautions▾
- For external (eye) use only — these drops should never be swallowed. If swallowed, call Poison Control at 1-800-222-1222 immediately.
- Overuse can make eye redness worse, not better — stick to the recommended frequency.
- If you have narrow angle glaucoma (a type of increased eye pressure), ask a doctor before using.
- Pupils may temporarily enlarge while you use this product.
- Do not use a solution that has changed color or appears cloudy.
- Stop use and see a doctor if symptoms do not improve within 72 hours.
🔀What it interacts with▾
The label does not list specific drug interactions for these eye drops, but a few practical precautions apply:
- Remove contact lenses before using — lenses can absorb the solution and may become contaminated
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your doctor if you have narrow angle glaucoma before using
- Ask a health professional before use if you are pregnant or breastfeeding
- Children under 6 years: consult a doctor first
- Children under 2 years: do not use
- Contact lens wearers: remove lenses before applying drops
🚑If you take too much▾
If these drops are swallowed — especially by a child — it can be dangerous. Get medical help or contact Poison Control at 1-800-222-1222 right away. Keep the product stored out of reach of children at all times.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F)
📄 Written from Tetrahydrozoline Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Tetrahydrozoline Ophthalmic — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly does this eye drop do — does it actually fix what's irritating my eye? ▾
Can I wear my contact lenses while using these drops? ▾
I've been using these drops every day for a while. Is that okay? ▾
My child's eyes are red — can I use these drops on them? ▾
I noticed my pupils look bigger after using the drops. Should I be worried? ▾
I'm pregnant — is it safe to use these eye drops? ▾
Is Tetrahydrozoline Ophthalmic available over the counter? ▾
When was Tetrahydrozoline Ophthalmic first available? ▾
Who makes Tetrahydrozoline Ophthalmic? ▾
💬 Answers drafted from Tetrahydrozoline Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Tetrahydrozoline Ophthalmic comes
Tetrahydrozoline Ophthalmic is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Eye drops
How this form is used
- Used to relieve redness of the eye due to minor eye irritations
- Adults and children 6 and over: place 1 or 2 drops in the affected eye(s) up to 4 times a day
- Remove contact lenses before applying drops
- Do not touch the dropper tip to any surface; replace the cap after each use
- Do not use if the solution has changed color or become cloudy
📊 Tetrahydrozoline Ophthalmic across the U.S. market
How Tetrahydrozoline Ophthalmic appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Tetrahydrozoline Ophthalmic is used
A general measure of how commonly Tetrahydrozoline Ophthalmic is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Tetrahydrozoline Ophthalmic is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Tetrahydrozoline Ophthalmic prescribed? Of the 1,596 medications we measure, Tetrahydrozoline Ophthalmic ranks #1,580 by Medicaid prescriptions — more than 1% of them.
Utilization by Tetrahydrozoline Ophthalmic product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution
Summed across the 1 of 52 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1052943
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Tetrahydrozoline Ophthalmic, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 1 of 52 listed Tetrahydrozoline Ophthalmic NDCs with Medicaid activity.
🔍 Compare Tetrahydrozoline Ophthalmic products
A representative set of FDA-listed product records for Tetrahydrozoline Ophthalmic — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 0.5 mg/mL | Ophthalmic | American Sales Company × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | AmerisourceBergen Drug Corporation × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | AmerisourceBergen Drug Corporation | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Cardinal Health | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Cardinal Health | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Chain Drug Marketing Assoc., Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Ophthalmic | Chain Drug Marketing Association Inc | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Discount Drug Mart, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Ophthalmic | Dolgencorp Inc | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Dolgencorp LLC × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Dolgencorp LLC | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Family Dollar Services, Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Geiss, Destin & Dunn, Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Geiss, Destin & Dunn, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Harris Teeter, LLC.P | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | HEB Grocery Company, LP | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Honeywell Safety Products USA, INC | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Honeywell Safety Products USA, INC | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Ophthalmic | Johnson & Johnson Consumer Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Ophthalmic | Kareway Product, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Ophthalmic | KC Pharmaceuticals, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Ophthalmic | KC Pharmaceuticals, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Ophthalmic | Kenvue Brands LLC | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Kinray × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Kinray | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Ophthalmic | Lil' Drug Store products, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Lil' Drug Store Products, Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Meijer Distribution, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Meijer Distribution, Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 mg/mL | Ophthalmic | New World Imports, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Ophthalmic | New World Imports, Inc × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Ophthalmic | Rite Aid Corporation × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Rugby Laboratories | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Rugby Laboratories | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Salado Sales, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Ophthalmic | Strategic Sourcing Services LLC | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Ophthalmic | Strategic Sourcing Services LLC | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Strategic Sourcing Services LLC | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Strategic Sourcing Services LLC × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | The Kroger Co. | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Topco Associates LLC | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Topco Associates LLC | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Ophthalmic | United Exchange Corp × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | United Natural Foods, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Valu Merchandisers Company | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Walgreens Company | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Walgreens Company | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Ophthalmic | Walmart, Inc. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Ophthalmic | Walmart Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | WinCo Foods, LLC | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Ophthalmic | WinCo Foods, LLC × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
Showing 67 of 67 products — FDA National Drug Code Directory. See every product, package size and price: browse all 67 Tetrahydrozoline Ophthalmic NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Tetrahydrozoline Ophthalmic — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Tetrahydrozoline Ophthalmic in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Tetrahydrozoline Ophthalmic went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 37935 2 dose forms · 2 strengths
-
Dose form (SCDF) Nasal Solution RxCUI 377447No current FDA listingClinical drug / strength (SCD) hydrochloride 0.5 MG/MLRxCUI 1232712 -
Dose form (SCDF) Ophthalmic Solution RxCUI 374067In current FDA listingsClinical drug / strength (SCD) hydrochloride 0.5 MG/MLRxCUI 1052943
Look up RxCUI 37935 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Tetrahydrozoline Ophthalmic is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 10 more on the FDA NDC directory.
RxNorm drug class
Tetrahydrozoline Ophthalmic belongs to the Sympathomimetics, plain class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 31 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Kenvue Brands LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.